SCHEMBL2524362

SCHEMBL2524362

COc1ccc(Cc2nc3c(O)ccc(C)c3[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10411490 0.99 — —
SCHEMBL10869402 0.87 — —
SCHEMBL10411966 0.86 — —
SCHEMBL10868119 0.86 — —
SCHEMBL10869286 0.85 — —
Hydrochloric Acid SCHEMBL10411406 0.85 — —
Hydrochloric Acid SCHEMBL10411967 0.84 — —
SCHEMBL10868107 0.83 — —
SCHEMBL10868700 0.83 POLB (0.52) —
SCHEMBL10411634 0.83 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048658-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-02-25 — — US claimed
US-8039500-B2 Fused heterocyclic compounds TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-10-18 — — US disclosed
US-20100048658-A1 FUSED HETEROCYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED 2010-02-25 — — US disclosed
Send feedback